The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas

Epithelial ovarian cancer is the most common cause of mortality from gynecologic malignancy, and most of epithelial cancers are of serous type. The site of origin of pelvic high-grade serous carcinoma has been the subject of debate for 60 years. This paper reviews the evidence that pelvic serous carcinoma originates from the fallopian tube mucosa and puts forward a theory that inflammation in the tube, caused by menstrual cytokines or infection, is critical to the genesis of these tumors. Other risk factors for pelvic serous carcinoma will be reviewed, including oral contraceptive use, parity, infertility, and tubal ligation. Studies were identified for this review by searching the English language literature in the MEDLINE database between the years 1995 and 2007 using the following keywords: fallopian tube neoplasia, ovarian serous adenocarcinoma, pregnancy, oral contraceptive, infertility, pelvic inflammatory disease, cytokines, menstruation, and tubal ligation, followed by an extensive review of bibliographies from articles found through the search. The clinical implications of this theory are discussed, and a change in surgical practice is recommended, with salpingectomy at the time of simple hysterectomy. This theory also has implications for the development of new methods of screening for pelvic serous carcinomas, as there are no screening methods that are currently available to find this form of cancer in an early stage. Inflammatory markers could be detected in the vagina from the fallopian tube indicating possible chronic inflammation and a risk factor for mutagenesis leading to serous carcinoma.

[1]  F. Gaytán,et al.  Macrophages in human fallopian tube and ovarian epithelial inclusion cysts. , 2007, Journal of reproductive immunology.

[2]  R. Berkowitz,et al.  Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship , 2007, The American journal of surgical pathology.

[3]  R. Drapkin,et al.  The distal fallopian tube: a new model for pelvic serous carcinogenesis , 2007, Current opinion in obstetrics & gynecology.

[4]  J. Garber,et al.  A candidate precursor to serous carcinoma that originates in the distal fallopian tube , 2007 .

[5]  P. Radice,et al.  Incidental Carcinomas in Prophylactic Specimens in BRCA1 and BRCA2 Germ-line Mutation Carriers, With Emphasis on Fallopian Tube Lesions: Report of 6 Cases and Review of the Literature , 2006, The American journal of surgical pathology.

[6]  P. Kyyrönen,et al.  Incidence of ovarian cancer of grand multiparous women--a population-based study in Finland. , 2006, Gynecologic oncology.

[7]  H. Chiu,et al.  Age at first birth, parity, and risk of death from ovarian cancer in Taiwan: a country of low incidence of ovarian cancer , 2006, International Journal of Gynecologic Cancer.

[8]  Christopher P Crum,et al.  The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome , 2006, The American journal of surgical pathology.

[9]  S. Gayther,et al.  Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention , 2006, Acta obstetricia et gynecologica Scandinavica.

[10]  T. Colgan,et al.  Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. , 2006, Gynecologic oncology.

[11]  B. Karlan,et al.  BRCA-Mutation–Associated Fallopian Tube Carcinoma: A Distinct Clinical Phenotype? , 2005, Obstetrics and gynecology.

[12]  I. Shih,et al.  Serous borderline tumours of the ovary , 2005, Histopathology.

[13]  C. la Vecchia,et al.  Breastfeeding and the risk of epithelial ovarian cancer in an Italian population. , 2005, Gynecologic oncology.

[14]  S. Bonovas,et al.  Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis. , 2005, British journal of clinical pharmacology.

[15]  P. Vercellini,et al.  Noncontraceptive health benefits of combined oral contraception. , 2005, Human reproduction update.

[16]  T. Moss,et al.  Failure of in vitro fertilization and embryo replacement following infection withChlamydia trachomatis , 1985, Journal of in Vitro Fertilization and Embryo Transfer.

[17]  Blossom Damania,et al.  Infectious agents and cancer: criteria for a causal relation. , 2004, Seminars in cancer biology.

[18]  M. Goodman,et al.  Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. , 2004, American journal of obstetrics and gynecology.

[19]  L. Brinton,et al.  Ovarian cancer risk associated with varying causes of infertility. , 2004, Fertility and sterility.

[20]  M. Pike,et al.  Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. , 2004, Fertility and sterility.

[21]  A. Strandell,et al.  The Presence of Cytokines and Growth Factors in Hydrosalpingeal Fluid , 2004, Journal of Assisted Reproduction and Genetics.

[22]  J. Olsen,et al.  Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women. , 2004, International journal of epidemiology.

[23]  J. Schlesselman,et al.  Safety concerns and health benefits associated with oral contraception. , 2004, American journal of obstetrics and gynecology.

[24]  Michael T Deavers,et al.  Grading Ovarian Serous Carcinoma Using a Two-Tier System , 2004, The American journal of surgical pathology.

[25]  M. J. van de Vijver,et al.  Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up , 2004, British Journal of Cancer.

[26]  C. la Vecchia,et al.  Risk factors for different histological types of ovarian cancer , 2003, International Journal of Gynecologic Cancer.

[27]  Miguel Rios,et al.  Expression of Proinflammatory Cytokines and Receptors by Human Fallopian Tubes in Organ Culture following Challenge with Neisseria gonorrhoeae , 2003, Infection and Immunity.

[28]  V. Beral,et al.  Long‐term effects of oral contraceptives on ovarian cancer risk , 2002, International journal of cancer.

[29]  N. Gupta,et al.  Malignant gonadal mesothelioma , 2002, Current treatment options in oncology.

[30]  Rochelle L. Garcia,et al.  Pathologic findings in prophylactic oophorectomy specimens in high-risk women. , 2002, Gynecologic oncology.

[31]  P. Dickman,et al.  Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. , 2002, American journal of epidemiology.

[32]  M. Sherman,et al.  Salpingitis, Salpingoliths, and Serous Tumors of the Ovaries: Is There a Connection? , 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[33]  M. Goodman,et al.  Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. , 2002, American journal of epidemiology.

[34]  P. V. van Diest,et al.  Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer , 2001, The Journal of pathology.

[35]  A. Gjorgov Tubal ligation and risk of ovarian cancer , 2001, The Lancet.

[36]  C. Isaacs,et al.  Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study , 2001, The Lancet.

[37]  R. Demopoulos,et al.  Clues to the Pathogenesis of Fallopian Tube Carcinoma: A Morphological and Immunohistochemical Case Control Study , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[38]  P. Leung,et al.  Ovarian surface epithelium: biology, endocrinology, and pathology. , 2001, Endocrine reviews.

[39]  H. Ngan,et al.  FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. , 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[40]  M. Morgan,et al.  Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. , 2000, Epidemiology.

[41]  J. Williams Noncontraceptive benefits of oral contraceptive use: an evidence-based approach. , 2000, International journal of fertility and women's medicine.

[42]  N. Weiss,et al.  Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer. , 1999, Epidemiology.

[43]  R. Ness,et al.  Possible role of ovarian epithelial inflammation in ovarian cancer. , 1999, Journal of the National Cancer Institute.

[44]  Z. A. McGee,et al.  Gonococcal infection of human fallopian tube mucosa in organ culture: relationship of mucosal tissue TNF-alpha concentration to sloughing of ciliated cells. , 1999, Sexually transmitted diseases.

[45]  A. Loercher,et al.  The role of cytokines in both the normal and malignant ovary. , 1999, Endocrine-related cancer.

[46]  A. Kaunitz Oral contraceptive health benefits: perception versus reality. , 1999, Contraception.

[47]  C. la Vecchia,et al.  Treatment for infertility and risk of invasive epithelial ovarian cancer. , 1997, Human Reproduction.

[48]  M. Cotterchio,et al.  Surgical procedures associated with risk of ovarian cancer. , 1997, International journal of epidemiology.

[49]  M. Quinn,et al.  Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer , 1997, International journal of cancer.

[50]  S. Kjaer,et al.  Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. , 1997, Fertility and sterility.

[51]  M. Thun,et al.  Tubal ligation and fatal ovarian cancer in a large prospective cohort study. , 1997, American journal of epidemiology.

[52]  K. Holmes,et al.  Acute Pelvic Inflammatory Disease: Associations of Clinical and Laboratory Findings With Laparoscopic Findings , 1997, Obstetrics and gynecology.

[53]  T. Cornelison,et al.  Tubal ligation and the risk of ovarian carcinoma. , 1997, Cancer detection and prevention.

[54]  D. Thomas,et al.  Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[55]  G. Gorini,et al.  The impact of oral contraception on chlamydial infection among patients with pelvic inflammatory disease. , 1996, Contraception.

[56]  P. Clement,et al.  Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas. , 1996, The American journal of surgical pathology.

[57]  C. la Vecchia,et al.  Pelvic inflammatory disease and risk of ovarian cancer. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[58]  A. Junod,et al.  Role of oxygen free radicals in cancer development. , 1996, European journal of cancer.

[59]  H. Risch,et al.  Pelvic inflammatory disease and the risk of epithelial ovarian cancer. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[60]  W C Willett,et al.  The causes and prevention of cancer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[61]  H. Adami,et al.  Parity, age at first childbirth, and risk of ovarian cancer , 1994, The Lancet.

[62]  H. Risch,et al.  Parity, contraception, infertility, and the risk of epithelial ovarian cancer. , 1994, American journal of epidemiology.

[63]  C. Wahlberg Tubal ligation, hysterectomy, and risk of ovarian cancer. , 1994, JAMA.

[64]  W. Willett,et al.  Tubal Ligation, Hysterectomy, and Risk of Ovarian Cancer: A Prospective Study , 1993 .

[65]  J. Grudzinskas,et al.  What is the true incidence of primary fallopian tube carcinoma? , 1993, International Journal of Gynecologic Cancer.

[66]  K. Mittal Morphologic precursors of ovarian epithelial tumors. , 1993, Obstetrics and gynecology.

[67]  C. Johannes,et al.  Re: "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women". , 1993, American journal of epidemiology.

[68]  A. Zeleniuch‐Jacquotte,et al.  Contralateral Ovary in Unilateral Ovarian Carcinoma: A Search for Preneoplastic Lesions , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[69]  A. Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[70]  B. Rosner,et al.  A quantitative assessment of oral contraceptive use and risk of ovarian cancer , 1992, Obstetrics and gynecology.

[71]  X. Bilian,et al.  Hormonal profile of the menstrual cycle in Chinese women after tubal sterilization. , 1992 .

[72]  B. Xiao,et al.  Hormonal profile of the menstrual cycle in Chinese women after tubal sterilization. , 1992, Contraception.

[73]  K. Teisala,et al.  Serologic Evidence for the Role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the Etiology of Tubal Factor Infertility and Ectopic Pregnancy , 1990, Sexually transmitted diseases.

[74]  A. K. Bhattacharyya,et al.  Structural changes in human cervical mucus. , 1989, The Indian journal of medical research.

[75]  J. Pastorek,et al.  Pelvic Inflammatory Disease During Pregnancy , 1987, Southern medical journal.

[76]  D. Cramer,et al.  Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. , 1983, Journal of the National Cancer Institute.

[77]  D. Cramer,et al.  Determinants of ovarian cancer risk. I. Reproductive experiences and family history. , 1983, Journal of the National Cancer Institute.

[78]  P. Layde,et al.  Oral contraceptives and pelvic inflammatory disease. , 1982, American journal of obstetrics and gynecology.

[79]  D. Cramer,et al.  Ovarian cancer and talc. A case‐control study , 1982, Cancer.

[80]  B. Ljung,et al.  Contractile patterns of isolated oviductal smooth muscle under different hormonal conditions. , 1980, Fertility and sterility.

[81]  I. Brosens,et al.  Fimbrial microbiopsy. , 1976, The Journal of reproductive medicine.

[82]  M F Fathalla,et al.  Incessant ovulation--a factor in ovarian neoplasia? , 1971, Lancet.

[83]  A. Hertig,et al.  Primary carcinoma of the fallopian tube. , 1950, American journal of obstetrics and gynecology.

[84]  E. Block Primary Carcinoma of the Fallopian Tube , 1947, Acta radiologica.

[85]  A. F. Brown,et al.  Carcinoma of the Fallopian Tube. , 1942, California and western medicine.